Replies to post #440271 on NorthWest Biotherapeutics Inc (NWBO)

[It Is What It Is]

How interesting. Another company that changed the trial endpoints post-facto. Whoops. This is not a good indicator for NWBO.

[biosectinvestor]

A journal article affords opportunity on the days following a journal article for lots and lots of positive coverage. It is something shorts would love to try to bet against, but they can’t.

[JohnnyMacJohnJohn]

This happens to biotechs so much it's unreal